Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-04-06Clinical Trial Update: Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes
Clinical trial update on non-invasive Cerenkov luminescence imaging to visualize lymphoma, leukemia, and metastatic lymph nodes; sponsored b…
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating busulfan, cyclophosphamide, and antithymocyte globulin followed by stem cell transplant for hematologic ca…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma [Phase 2]
A multicenter Phase 2 trial sponsored by PharmaMar for relapsed/refractory aggressive non-Hodgkin lymphoma has completed enrollment and post…
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System [Phase 1, Phase 2]
A phase 1/2 trial of intrathecal rituximab for lymphoid malignancies involving the central nervous system was terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
The PENELOPE observational study, which examined prophylaxis and treatment of arterial and venous thromboembolism in patients with hematolog…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-03-19Clinical Trial Update: Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 Years, With Haematological Malignancies, and Managed Between 2000 and 2016
This clinical trial update reports a unicentric retrospective analysis of 602 young adult and adolescent patients (ages 15-30) with hematolo…
-
CLINICAL_TRIALS trial_result · 2018-03-16Clinical Trial Update: Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies [Phase 2]
Phase 2 trial of non-myeloablative HLA-mismatched ex-vivo T-cell depleted stem cell transplantation for hematologic malignancies was termina…
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies [Phase 2]
A Phase 2 study of non-Myeloablative HLA-matched ex-vivo T-cell depleted stem cell transplantation for hematologic malignancies was terminat…
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia [Phase 2]
This document reports the completion of a Phase II clinical trial evaluating perifosine in patients with refractory or relapsed leukemia.
-
CLINICAL_TRIALS trial_result · 2018-01-29Clinical Trial Update: Paricalcitol in Treating Patients With Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating paricalcitol in patients with myelodysplastic syndrome; study completed.
-
CLINICAL_TRIALS trial_result · 2018-01-12Clinical Trial Update: A Feasibility Study of Prophylactic White Blood Cell Transfusions [Phase 2]
Phase 2 feasibility study evaluating prophylactic white blood cell transfusions in leukemia patients has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS [Phase 2]
Phase 2 trial update of azacitidine plus lenalidomide in elderly patients with previously treated acute myeloid leukemia and high-risk myelo…
-
FDA approval · 2017-12-18FDA Approved: BUSULFAN — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' busulfan Original Application, establishing a generic version of busulfan for clinical use.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating the safety and potential antitumor effects of atorvastatin in Non-Hodgkin lymphoma; study completed with results po…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma [Phase 1]
Phase 1 clinical trial update for DT2219ARL in relapsed or refractory CD19+/CD22+ B-lineage leukemia or lymphoma.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases [Phase 1]
Phase 1 trial evaluating the safety of Umbilical Cord Blood T-Regulatory Cell infusion followed by donor cord blood transplant in patients w…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating infusion of regulatory T cells after umbilical cord blood transplant in patients with advanced hematologic…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer [Phase 1, Phase 2]
A Phase 1/2 trial update on using combination chemotherapy and total-body irradiation before donor umbilical cord blood transplant in patien…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 1]
A Phase 1 trial evaluating donor T cells in high-risk hematologic cancers undergoing donor peripheral blood stem cell transplant was termina…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant [Phase 1]
A Phase 1 trial assessing CpG 7909 in patients who have undergone autologous stem cell transplant has been terminated. The study included pa…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [NA]
ClinicalTrials.gov entry describes termination of a study evaluating donor umbilical cord blood transplantation for various hematologic canc…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia [Phase 1]
The update reports termination of a Phase 1 trial evaluating AHN-12, a Yttrium-90 labeled anti-CD45 monoclonal antibody, in advanced leukemi…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer [NA]
This clinical trial update reports completion of a study evaluating chemotherapy and total-body irradiation followed by donor umbilical cord…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors [NA]
The document reports a completed University of North Carolina clinical trial studying survivorship and psychological outcomes in bone marrow…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Chinese Herbal Medicine for Immune Reconstitution Following HSCT in Acute Leukemia Patients [NA]
A completed clinical trial evaluated Chinese herbal medicine for immune reconstitution after hematopoietic stem cell transplantation in pati…